Miami Herald - Thursday, June 7, 2001
Pfizer announced the program, developed with the United Nations and World Health Organization, at the UN. There is no time limit on the offer. Pfizer expects to provide about $50 million worth of Diflucan to 100,000 people in the next two years in South Africa alone.
About half of Diflucan's $1 billion in 2000 sales were made in the U.S., where the drug is advertised for treating vaginal yeast infections. Diflucan also can treat mild cases of fungal brain infections, which occur in about 10 percent of patient with advanced AIDS. Diflucan can then be continued to ward off recurrence of these infections.
010607
MH010606
Copyright © 2001 - Miami Herald. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Miami Herald, Permissions, One Herald Plaza, Miami, FL 33132-1693 TEL: (305) 376-3719. http://www.herald.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .